[ad_1]
A decision on this is scheduled for Monday.
According to the draft prepared, the Government of Lithuania would not approve the purchase of additional doses of the vaccine against the COVID-19 disease envisaged in the preliminary agreement with the pharmaceutical company Janssen Pharmaceutica NV.
“The vaccine is not suitable for maintaining immunity because of its platform,” says SAM.
Furthermore, according to her, Lithuania has already approved 0.7 million. doses of this vaccine will be delivered at the end of these and will guarantee the need for vaccination.
The government has already approved the purchase of the AstraZeneca vaccine: 1.86 million. dose, Janssen Pharmaceutica NV – 0.7 million. doses, Sanofi Pasteur & GSK 1.5 million doses, CureVac – 1.38 million. dose, Modern – 0.506 million. dose, BioNTech & Pfizer: 9.296 million. Novavax dose 0.633 million. dose, Valneva – 0.372 million. dose.
Some vaccines are not yet registered with the European Medicines Agency.
It is not allowed to publish, quote or reproduce the information of the BNS news agency in the media and on websites without the written consent of the UAB “BNS”.
[ad_2]
